Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for pediatric septic shock
ChiCTR2000035902Phase 4Recruiting
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylprednisolone in septic shock (3 arms), sponsored by Shengjing Hospital of China Medical University. Primary endpoint: All-cause mortality. Started Oct 2020; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
septic shock
Beyond the preview
Go deeper on ChiCTR2000035902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035902.